Nova Eye Medical (AU:EYE) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Nova Eye Medical Limited has announced changes in the securities interests of its director, Thomas Anthony Spurling. The director’s direct and indirect holdings have increased following the lapse of 700,000 options. This update may influence investor sentiments as it reflects a shift in insider holdings.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.
